Tuberous sclerosis complex (TSC) is a dominantly inherited disorder of hamartomas and hamartia with an estimated population frequency of 1 in 10,000. Both hamartomas and hamartia represent developmental anomalies characterized by abnormal cell or tissue arrangement and defective function. Hamartomas are distinguished by the additional feature of excessive cellular proliferation. The hamartomas do not usually progress to malignancy but cause morbidity and mortality due to size and location. Nearly every organ system has been reported to have the tumors in affected individuals; however, the most severe effects are in the CNS. Primary sources of morbidity are seizures (80-90% of affected individuals), mental retardation (40-50% of affected individuals) and behavioral abnormalities (most prominently autism; up to 50% of affected individuals). Efforts to clone the responsible genes have been extensive. Through genetic linkage studies, we know that there are two genes (on chromosomes 9q34 and 16p13) which probably account for all familial cases. The goal of this project is to clone the TSC gene on chromosome 9q34. Through genetic mapping studies, the critical TSC region on 9q34 has been narrowed to a genetic distance of two centimorgans and a physical region of less than two metabases. The project is moving from the genetic mapping phase into the physical mapping phase. Initially, I will continue genetic mapping studies by finding new families with multiple mapping phase. Initially, I will continue genetic mapping studies by finding new families with multiple affected individuals to identify additional key recombinants. Yeast artificial chromosome (YACs) which cover the critical region are being obtained from YAC libraries and by a new marker-specific method which is described. Candidate genes (by location) will be isolated from the region by Alu-PCR, zoo blotting, exon trapping and a novel in-vitro splicing technique. Candidate genes (by function) will be sought by screening the region for trinucleotide repeat sequences and screening the YACs at low stringency for functional motifs such as those know to serve in cell cycle regulation. Mutations to define the TSC gene will be searched for by: Southern blotting searching for large deletions, insertions and rearrangements; sequencing of candidates cDNAs to perform SSCP seeking point mutations and small deletions or insertions; and sequencing of DNAs from affected individuals in the event that the other two deletions or insertion; and sequencing of DNAs from affected individuals in the event that the other two strategies are unsuccessful. Once found, the TSC gene will be compared in normal and affected individuals to uncover more information about the disease and facilitate diagnosis and management.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS032300-02
Application #
2270366
Study Section
Neurology C Study Section (NEUC)
Project Start
1994-01-01
Project End
1998-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Au, Kit Sing; Williams, Aimee T; Roach, E Steve et al. (2007) Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 9:88-100
Tarler, Matthew D; Mortimer, J Thomas (2004) Selective and independent activation of four motor fascicles using a four contact nerve-cuff electrode. IEEE Trans Neural Syst Rehabil Eng 12:251-7
Tarler, Matthew D; Mortimer, J Thomas (2003) Comparison of joint torque evoked with monopolar and tripolar-cuff electrodes. IEEE Trans Neural Syst Rehabil Eng 11:227-35
Grill, W M; Mortimer, J T (2000) Neural and connective tissue response to long-term implantation of multiple contact nerve cuff electrodes. J Biomed Mater Res 50:215-26
Au, K S; Hebert, A A; Roach, E S et al. (1999) Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J Hum Genet 65:1790-5
Rose, V M; Au, K S; Pollom, G et al. (1999) Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet 64:986-92
Grill, W M; Mortimer, J T (1998) Stability of the input-output properties of chronically implanted multiple contact nerve cuff stimulating electrodes. IEEE Trans Rehabil Eng 6:364-73
Au, K S; Rodriguez, J A; Finch, J L et al. (1998) Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genet 62:286-94
Au, K S; Rodriguez, J A; Rodriguez Jr, E et al. (1997) Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16. Hum Mutat 9:23-9
Rodriguez, J A; Evans, R L; Daiger, S P et al. (1997) Molecular analysis of the human vitamin D binding protein (group specific component, Gc) in tuberous sclerosis complex (TSC). J Med Genet 34:509-11

Showing the most recent 10 out of 15 publications